Gabbi’s Post

Cancer rates are increasing among Americans under 50, a trend that unfortunately is not predicted to end soon. I wrote a few thoughts on an article that was shared with me, now is a crucial time to prioritize cancer awareness. Gabbi is taking the lead and empowering all women to understand their breast cancer risk. #earlydetectionsaveslives #breastcancer #womenshealth

Another piece of evidence has been added to the longstanding debate about when annual breast cancer screening should begin. Starting at age 40, and continuing to at least age 79, provides the highest reduction in mortality with minimal risks, according to a new study published recently in Radiology. “The biggest takeaway point of our study is that annual screening beginning at 40 and continuing to at least age 79 gives the highest mortality reduction, the most cancer deaths averted, and the most years of life gained,” said lead researcher Debra L. Monticciolo, MD, professor of radiology at Dartmouth Geisel School of Medicine in Hanover, New Hampshire. “There’s a huge benefit to screening annually until at least 79 and even more benefit if women are screened past 79.” Breast cancer is the second most common cause of cancer death for women in the U.S. About 4,200 women and 500 men die from the disease annually in this country alone. Screening mammography can reduce breast cancer deaths by 40%, but only 50% or fewer of eligible women actually participate in annual screening. Yet today’s mammography uses less radiation and newer techniques are more accurate, reducing the need for unnecessary biopsies. #breastcancer #mammography

I shared my thoughts with Time earlier this week about the U.S. Preventative Services Task Force’s final recommendations on breast cancer screening. The revision for breast cancer screening beginning at 40 rather than 50 is long overdue. The data have shown that by not screening women between ages 40 and 50, women in that age group who do develop breast cancer often have more aggressive cancers which may lead to poorer outcomes, are more likely to need chemotherapy, more likely to need larger surgery. The Task Force is late to the party on making this change as cancer rates are rising in younger adults. They are also falling short on their guidelines by not altering guidelines for black women to start screening earlier with the potential for supplemental imaging despite their acknowledgment that black women are at higher risk for breast cancer and at an early age. AND, as the FDA will shortly mandate that all women be notified of their breast density with the recommendation to speak to their doctors regarding the need for additional imaging, the Task Force is not recommending supplemental imaging! Continued advocacy is needed where these guidelines fall short. #FindItEarlyAct #EarlyDetectionSavesLives https://lnkd.in/dr6HwMrc

✨ Exciting Update in Breast Cancer Screening Guidelines ✨ The U.S. Preventive Services Task Force has recently updated its guidelines for Breast Cancer Screening, now recommending biennial screening mammography for women aged 40 to 74 years. This is aligned with other organizations: The American College of Radiology, the Society of Breast Imaging, the American College of Obstetricians and Gynecologists, and the NCCN, that also advocate for initiating mammography screening at age 40 for women at average risk. 🤔 However, no specific recommendations for dense breasts have been made, stating that “the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening using ultrasound or MRI”. 🔎 As we celebrate progress in breast cancer screening, it’s imperative to address the disparities and challenges faced by women with dense breast tissue. 👩🔬 At The Blue Box Biomedical Solutions we are working to face this challenge, offering a non-invasive and highly accurate method for detecting breast cancer, unaffected by breast density. We aim to facilitate earlier detection for all women, regardless of breast density. 🗣️💬 What other steps can we take to overcome the limitations of dense breast tissue in cancer screening? How can we advocate for greater inclusivity and accessibility in screening programs? Feel free to share your insights! 🖇 Articles Links: - https://lnkd.in/dy93fhSF. https://lnkd.in/dDNPAWji /

Breast Biopsy Devices Market worth $2.6 billion by 2028 Download PDF Brochure @ https://lnkd.in/dpHpjSTB 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐫𝐞𝐚𝐬𝐭 𝐛𝐢𝐨𝐩𝐬𝐲 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $1.6 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $2.6 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 10.0% 𝐟𝐫𝐨𝐦 2023 𝐭𝐨 2028 Globally, the most frequently occurring cancer among women; it affects around 2.26 million women across the globe. In 2020, an estimated 685,000 deaths were caused owing to #breastcancer, accounting for 15% of cancer-related deaths among women. A key contributor to the high death rate is that most women are diagnosed with late-stage cancer. •                   The 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐫𝐞𝐚𝐬𝐭 𝐚𝐧𝐝 𝐂𝐞𝐫𝐯𝐢𝐜𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐄𝐚𝐫𝐥𝐲 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 (𝐍𝐁𝐂𝐂𝐄𝐃𝐏) was initiated by the Centers for Disease Control and Prevention (CDC) in 1991 for early breast and cervical cancer detection in the #US. This program aims to provide annual breast cancer screening and diagnosis for uninsured and low-income women in the country. In 2021, NBCCEDP provided breast cancer screening and diagnostic services to 263,651 women and diagnosed 2,221 invasive breast cancers and 676 premalignant breast lesions. •                   The rising number of such initiatives in major global markets is expected to increase the number of screening procedures for breast cancer diagnosis. This, in turn, is expected to drive the growth of the breast biopsy market. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: BREAST BIOPSY SERVICES, L.C. Breast Imaging Victoria Altimate Medical Seno Medical INRAD Northwest Radiology Network Breast Center At Hope Morehead Memorial Hospital SenoRx Fischer Medical Fischer Imaging Montclair Radiology Associates Southtowns Radiology Elizabeth Wende Breast Care Strand Diagnostics/Know Error Vancouver Radiologists Akira Medical Imaging + Wellness Muskogee Community Hospital - Purchased by St. Francis - Purchased by St. Francis Austin Breast Imaging St. Joseph's Imaging Vista Radiology, PC California Imaging and Diagnostics

According to a new Canadian study, some women with early-stage #cervicalcancer can be safely treated with a less-invasive #hysterectomy that has fewer complications. The current standard treatment for early-stage cervix cancer is a radical hysterectomy, removing not only the uterus and cervix, but also the surrounding tissue and up to one-third of the vagina. Alternatively, the researchers found that women who had a simple hysterectomy (a less-invasive procedure wherein the surrounding tissue and most of the vagina remain intact) were at no higher risk of #cancer recurring in the pelvic area after three years than those who had a radical hysterectomy. Also, women who underwent a radical hysterectomy were more likely to have #urinaryincontinence (loss of bladder control) and sexual side-effects after surgery. However, the simple hysterectomy should only be an option for cervical cancer patients who have early-stage disease, with superficial lesions less than or equal to 2 centimeters and do not have lymph node involvement. There has been a gradual trend whereby physicians have started to suggest less radical surgery is sufficient for these select patients and the results of this study further substantiate that less-invasive surgery is also a safe option for patients. 🌟 Join the fight against women's cancers. Donate to WCRF today and help us make groundbreaking advancements in cancer research. Every contribution counts. 💪 [Link in bio] https://lnkd.in/e-wm3RcX #SupportWCRF #DonateNow #cancerresearch

What is breast cancer? | program #Emirates_Morning. Breast cancer is a disease in which abnormal breast cells grow out of control and form tumours. If left unchecked, the tumours can spread throughout the body and become fatal. Breast cancer cells begin inside the milk ducts and/or the milk-producing lobules of the breast. The earliest form (in situ) is not life-threatening and can be detected in early stages. Cancer cells can spread into nearby breast tissue (invasion). This creates tumours that cause lumps or thickening.  Invasive cancers can spread to nearby lymph nodes or other organs (metastasize). Metastasis can be life-threatening and fatal. Treatment is based on the person, the type of cancer and its spread. Treatment combines surgery, radiation therapy and medications. Scope of the problem In 2022, there were 2.3 million women diagnosed with breast cancer and 670 000 deaths globally. #BreastCancer occurs in every country of the world in women at any age after puberty but with increasing rates in later life.  Global estimates reveal striking inequities in the breast cancer burden according to human development. For instance, in countries with a very high Human Development Index (HDI), 1 in 12 women will be diagnosed with breast cancer in their lifetime and 1 in 71 women die of it. In contrast, in countries with a low HDI; while only 1 in 27 women is diagnosed with breast cancer in their lifetime, 1 in 48 women will die from it.

We're glad to see the recommended age for mammograms is back to age 40 for those with average risk in the recent guidelines by the U.S. Preventive Services Task Force, however we believe there's more to be done. We need annual screenings instead of every other year, more proactive options for younger people at higher-risk, routine discussions about breast cancer risk with doctors starting at age 30, and specialized imaging for those with dense breast tissue. Get the facts about mammograms at https://bit.ly/3UH9lzh

As the tide changes and all things evolve, cancer of the breast is one of deadly cancer that is commonly diagnosed in the women population. The initiation of mammography screening has tackled the mortality rate of breast cancer. The desire to improve early breast cancer detection has led to the technological evolution of other imaging modalities such as breast MRI and breast sonogram although mammography is the gold standard for breast cancer screening. Most breast cancers are occult when conventional mammography screening is carried out but the advent of digital mammography encouraged research in the use of contrast in digital mammography to demonstrate these cancers giving rise to what we know today as contrast-enhanced digital mammography. By using the concept of angiogenesis in tumors, contrast-enhanced digital mammography(CEDM) enhances the parts of blood vessel proliferation that correspond to the normal breast tissue surrounding as a result of inflow of contrast to these parts. This technique received FDA clearance in 2011. Contrast-enhanced digital mammography (CEDM) has proven to be a valuable tool that is currently applied in high-risk breast screening, surgical planning, breast cancer staging, further evaluation of extremely dense breast tissue, suspicious assessment of suspicious lesions, and assessment of treatment response . Contrast-enhanced digital mammography can be used for supplemental breast screening and has proven to detect malignancy as well as avoid false-negative results when compared to 2D mammography. Nevertheless, more researches are being carried out relative to this uprising technology, there is more than enough room for improvement where some limitations encountered recently will likely become a thing of the past.

Breast cancer doesn’t discriminate. Anyone – female or male – can be diagnosed with breast cancer at any age. But at the Nancy N. and J.C. Lewis Cancer & Research Pavilion, we treat each case individually to customize a treatment plan just for you. One such treatment option we may find best suited for you is radiation therapy using inspiratory breath-hold technique and prone positioning. Breast cancer is a very common cancer in women, says Dr. John Pablo, radiation oncologist and medical director of the Radiation Oncology Center at the Lewis Cancer & Research Pavilion. One in eight women will be diagnosed with breast cancer over the course of a lifetime. Men can get breast cancer, too. One percent of all breast cancers are diagnosed in men. The good news is that breast cancers can be found earlier thanks to the fact that advancements in screening diagnosis and treatment have greatly improved. One treatment option for breast cancer is radiation therapy, an important component of a multidisciplinary process to optimally treat breast cancer, Dr. Pablo says. Approximately 70 percent of women with breast cancer undergo a surgical procedure called a lumpectomy, where the cancerous mass is removed, not the entire breast. Nearly all of those women will receive radiation following a lumpectomy, Dr. Pablo explains. Approximately 30 percent of women with breast cancer undergo a mastectomy, a surgical procedure where the entire breast is removed. Twenty to 30 percent of those patients require radiotherapy following surgery, Dr. Pablo says. More at https://lnkd.in/dva3M9h #breastcancer #breastcancersurvivor #breastcancertreatment #cancer #cancertreatment #radiationoncology #radiationtherapy #radiationoncologist #radiotherapy